Rovida Advisors’s Xometry XMTR Stock Holding History

Rovida Advisors’s Portfolio XMTR Stock Details XMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-30,000	Closed	-$1.1M	–	29
2022 Q1	$1.1M	Sell	30,000 -75,000	-71%	-$3.43M	0.24%	27
2021 Q4	$5.38M	Buy	105,000 +4,349	+4%	+$224K	0.24%	40
2021 Q3	$5.78M	Buy	100,651 +40,651	+68%	+$2.82M	0.24%	41
2021 Q2	$5.13M	Buy	+60,000	New	+$5.24M	0.22%	35

Other funds holding XMTR

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HMP9

Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return

Foundry Group Boulder, Colorado $209M AUM 47.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rovida Advisors's XMTR Position: Q2 2022 in Review

Rovida Advisors sold out of Xometry (XMTR) in Q2 2022, closing a stake of 30,000 shares — an estimated $1.1M sold.

Rovida Advisors first reported a position in XMTR in Q2 2021 and held it in 4 quarters. The position peaked at $5.78M in Q3 2021. 120 funds tracked by Wall St. Rank hold XMTR as of Q2 2022.

Rovida Advisors reported no remaining Xometry position as of Q2 2022 after selling out during the quarter.
Rovida Advisors sold 30,000 Xometry shares in Q2 2022, an estimated $1.1M.
Rovida Advisors first reported a position in Xometry in Q2 2021 and held it in 4 quarters.
Rovida Advisors's Xometry position peaked at $5.78M in Q3 2021.
120 funds tracked by Wall St. Rank held Xometry as of Q2 2022.

Based on Rovida Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.